The presence of a high number of TAMs with a CD68+ phenotype and infiltrating CD8+ cytotoxic lymphocytes has led to the identification of two immunogenic CRC subtypes, namely, consensus molecular subtype 1 (CMS1) and CMS4 [9]. The gene discussed is CD8A; the disease is colorectal carcinoma.